Astrazeneca Pharma India, an integrated biopharmaceutical company, posted net loss of Rs 176.95 million for the quarter ended Dec. 31, 2012 as compared to net profit of Rs 149.37 million for the same period in the previous year.
Net sales has decreased 31.65% to Rs 1.05 billion for the quarter ended Dec 31, 2012 from Rs 1.54 billion for the same period in the previous year.
Shares of AstraZeneca declined Rs 2.65, or 0.2%, to settle at Rs 1,323.65. The total volume of shares traded was 2,529 at the BSE (Wednesday).
Astrazeneca Pharma India Limited (Q,N,C,F)*